November 19, 2025
Webinar: Pharmacy SIG Journal Club
Virtual | 2-3 p.m. CT
The pharmacy journal club webinar consists of two, 30-minute journal club presentations. The November Journal Club sessions will cover PTCy-based GVHD Prophylaxis after mismatched unrelated donor peripheral blood stem cell transplant and CAR-T Therapy for Richter Transformation.
Virtual
December 02, 2025
Webinar: Innovations in CAR T
Virtual | 12-1 p.m. CT
Join us for an engaging and informative session exploring the latest innovations in CAR T-cell therapy. This program will feature two leading experts who will share insights across the spectrum of patient care.
Virtual
December 10, 2025
Webinar: Assessing Physical Function in Transplantation and CAR T Recipients
Virtual | 12-1 p.m. CT
Presented by the ASTCT Survivorship SIG, this panel-based webinar will focus on identifying our current physical assessment tools to guide the practice of pre-HCT evaluation of physical function.
Virtual
December 11, 2025
Webinar: BMT Across the World: Who Makes What and Who Pays Whom?
Virtual | 9-10 a.m. CT
The clinical, logistical and administrative landscape behind BMT therapies can vary significantly across the world. In this webinar, we will use case studies to highlight country-specific considerations with regard to donor selection and survivorship.
Virtual
December 18, 2025
Webinar: CAR-T Therapy Across the World: Who Makes What and Who Pays Whom?
Virtual | 9-10 a.m. CT
Sexual dysfunction is a well-known adverse event after transplant; however, is under-recognized and under-treated. We will review barriers to discussions surrounding sexual health after transplant as well as strategies to approach this and the role of a dedicated sexual health clinic.
Virtual
February 04 - 07, 2026
Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR®
Salt Lake City, UT
The Tandem Meetings are a multidisciplinary event highlighting the latest research and breakthroughs in the evolving field of hematopoietic cell transplantation (HCT), cellular therapy and gene therapy.
Hybrid